Marinus Pharmaceuticals Inc., a biopharmaceutical company dedicated to the development of innovative therapeutics to treat epilepsy and neuropsychiatric disorders, has named Jaakko Lappalainen, as vice president of clinical development and Kimberly McCormick, as head of regulatory affairs. Dr. Lappalainen has 10 years of experience in the design, monitoring, interpretation and reporting of clinical trials at pharmaceutical research and development companies, including AstraZeneca. Dr. McCormick ...